From L-R: UVA president Jim Ryan, Gov. Glenn Youngkin (R-VA), Paul Manning, UVA Health CEO K. Craig Kent and university rector Whitt Clement at Friday’s announcement (Photo by Erin Edgerton, University Communications courtesy University of Virginia)
January 23, 2023 10:23 AM EST
People
Financing

VC in­vestor Paul Man­ning do­nates $100M to UVA for new R&D in­sti­tute

Paul Schloesser

Associate Editor

PBM Cap­i­tal’s Paul Man­ning has do­nat­ed $100 mil­lion to the Uni­ver­si­ty of Vir­ginia, and it’s go­ing to be used to ad­vance drug de­vel­op­ment.

At a cer­e­mo­ny on cam­pus Fri­day, lead­ers from across the uni­ver­si­ty and UVA Health an­nounced the launch of the Paul and Di­ane Man­ning In­sti­tute of Biotech­nol­o­gy. State of­fi­cials, in­clud­ing Vir­ginia Gov. Glenn Youngkin and Vir­ginia House of Del­e­gates Speak­er Todd Gilbert, were al­so present.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Cash, chips and tal­ent: In­side Nvidi­a's plan to dom­i­nate biotech's AI rev­o­lu­tion

Re­gen­eron en­ters ven­ture in­vest­ing with $500M, poach­es se­nior part­ner from ARCH

Ver­tex, Alpine’s IgAN drug has Hu­mi­ra-like po­ten­tial. But not all in­di­ca­tions are cre­at­ed equal

A ma­jor­i­ty of phar­ma and biotech com­pa­nies pro­hib­it Chat­G­PT use, sur­vey finds

GSK un­veils long-term Shin­grix da­ta as shin­gles com­pe­ti­tion heats up

Sen­ate bill tar­get­ing WuXi won't af­fect fed­er­al spend­ing, CBO says

A service from the Financial Times